Providing market intelligence for more than 35 years

In The News

Comcast Xfinity Home And Amazon Talk IoT Strategy At CONNECTIONS Conference

Parks Associates held their CONNECTIONS conference this week with sessions and keynotes that examined the innovations, business models, and trends around the connected (or smart) home market. Among the highlights: two first-day keynote sessions from Daniel Herscovici, Senior Vice President and GM at Comcast Xfinity Home and David Isbitski, Chief Evangelist for Alexa and Echo at Amazon.

“Today’s average U.S. broadband household owns over eight connected CE devices, an increase from less than seven in 2013,” Stuart Sikes, President of Parks Associates, said in a statement. “CONNECTIONS attendees gained enormous insight today from Amazon and Comcast about how companies are capturing market share by embracing the next phase of the connected home.”

From the article "Comcast Xfinity Home And Amazon Talk IoT Strategy At CONNECTIONS Conference" by Rob Stott.

Previously In The News

Cord-Cutting On The Rise In The US

“Pay TV subscriptions have dropped each year since 2014, falling to 81% of US broadband households in Q3 2016,” said Brett Sappington, senior director of research, Parks Associates. “Several factor...

Parks: US Churn Rate For OTT Services Is 19%

This is according to Parks Associates’ latest ‘OTT Video Market Tracker’ stats, which said that overall churn rate for OTT services has been roughly stable for the past year. At the end of 2015, 20...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...